1. Home
  2. BUR vs NEO Comparison

BUR vs NEO Comparison

Compare BUR & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burford Capital Limited

BUR

Burford Capital Limited

HOLD

Current Price

$4.99

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.43

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BUR
NEO
Founded
2009
2001
Country
Guernsey
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2017
2008

Fundamental Metrics

Financial Performance
Metric
BUR
NEO
Price
$4.99
$8.43
Analyst Decision
Buy
Buy
Analyst Count
3
7
Target Price
$13.58
$11.14
AVG Volume (30 Days)
6.1M
1.4M
Earning Date
05-06-2026
04-28-2026
Dividend Yield
2.68%
N/A
EPS Growth
N/A
N/A
EPS
0.28
N/A
Revenue
$413,360,000.00
N/A
Revenue This Year
$104.62
$10.63
Revenue Next Year
N/A
$9.73
P/E Ratio
$16.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.59
$4.72
52 Week High
$14.61
$13.74

Technical Indicators

Market Signals
Indicator
BUR
NEO
Relative Strength Index (RSI) 37.83 51.59
Support Level $3.59 $7.33
Resistance Level $9.59 $8.89
Average True Range (ATR) 0.30 0.45
MACD 0.13 0.17
Stochastic Oscillator 97.31 81.79

Price Performance

Historical Comparison
BUR
NEO

About BUR Burford Capital Limited

Burford Capital Ltd provides capital against the underlying value of litigation and legal assets, known as legal finance, serving the legal industry with financial products and services. Its business is funding clients engaged in ongoing legal disputes to pay legal fees and monetize the expected future value of disputes, focusing on large, complex matters. The company has two reportable segments: Principal Finance, which earns maximum revenue and allocates capital to legal finance assets from its balance sheet and through interests in private funds managed by the company, and Asset Management and Other Services, which manages legal finance assets for third-party investors and provides other services to the legal industry.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: